Navigation Links
Jazz Pharmaceuticals Reports Full Year And Fourth Quarter 2012 Financial Results
Date:2/26/2013

69-26,360-Psychiatry:Luvox CR

10,7859,09042,41933,170FazaClo LD (1)

4,118-22,023-FazaClo HD (1)

3,068-12,047-Other (1)

10,165-26,932-Total

$ 181,942$ 80,935$ 580,527$ 266,518 (1) Net sales for the year ended December 31, 2012 reported by Jazz Pharmaceuticals plc include net sales from the historic Azur Pharma business for the period beginning January 18, 2012 and net sales from the historic EUSA Pharma business beginning June 12, 2012.  

The following unaudited pro forma information represents the combined net product sales for the three months and years ended December 31, 2012 and 2011, respectively, as if the merger with Azur Pharma, the acquisition of EUSA Pharma and the disposition of the women's health business had each been completed on January 1, 2011:  SUMMARY OF PRODUCT SALES, NET (PRO FORMA)  (In thousands)  (Unaudited) Three Months EndedYear EndedDecember 31,December 31,2012201120122011Xyrem

$ 113,514$   71,845$ 378,663$ 233,348Erwinaze/Erwinase

34,42318,534131,87044,220Prialt 

5,8695,77326,69920,600Psychiatry:Luvox CR

10,7859,09042,41933,170FazaClo LD

4,1188,09022,25630,105FazaClo HD

3,0683,14312,1778,681Other

10,16512,68848,87352,622Total pro forma net sales

$ 181,942$ 129,163$ 662,957$ 422,746 JAZZ PHARMACEUTICALS PLCCONDENSED CONSOLIDATED BALANCE SHEETS(In thousands) (Unaudited) December 31,December 31,20122011ASSETSCurrent assets:Cash and cash equivalents

$
387,196$
82,076Marketable securities

-75,822Accounts receivable

75,48034,374Inventories

26,5253,909Prepaid expenses

7,4451,690Deferred tax assets, net

35,813-Other current assets

19,1131,260Total current assets

551,572199,131Property and equipment, net

7,2811,557Intangible assets, net


'/>"/>
SOURCE Jazz Pharmaceuticals plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
2. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
3. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
4. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
5. Icahn Issues Statement Regarding Amylin Pharmaceuticals
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
8. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
9. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
10. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
11. Avanir Pharmaceuticals To Present at Three Conferences In May
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)...  According to Millennium Research Group (MRG), the global ... the United States and European transcatheter ... moderately through 2022, with embolization particles representing one ... in drug-eluting beads (DEBs) and radioembolization spheres in ...
(Date:1/15/2014)... YORK , Jan. 15, 2014 ... market research report is available in ... Global Markets and Technologies for Advanced ... Routes of Administration ...
(Date:1/14/2014)... HAMILTON, N.J. , Jan. 14, 2014 InformEx, ... buyers and sellers of high-value chemistry, will hold the 30 ... Miami Beach Convention Center from January 21-24. ... than 3,500 attendees from top pharmaceutical, fine chemical and specialty ...
Breaking Medicine Technology:US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
... 30, 2012  Today, in conjunction with its Investor Day being ... PRXL ) announced forward-looking earnings expectations for the ... for Fiscal Year 2012, and for Fiscal Year 2013.  ... quarter of Fiscal Year 2012 and for all of Fiscal ...
...  Stiefel, a GSK (NYSE: GSK ) company, ... agreement for the acquisition by Stiefel of exclusive development ... in all territories outside of China, Taiwan, Macao and ... development for the treatment of psoriasis and atopic dermatitis. ...
Cached Medicine Technology:PAREXEL International Issues Earnings Guidance In Conjunction With Investor Day 2PAREXEL International Issues Earnings Guidance In Conjunction With Investor Day 3PAREXEL International Issues Earnings Guidance In Conjunction With Investor Day 4Stiefel, a GSK company, enters agreement with Welichem Biotech, Inc. to acquire a novel topical agent for psoriasis and atopic dermatitis 2
(Date:4/14/2014)... HIV/AIDS in South Africa may provide insight on how to ... areas of the world, which may have limited access to ... , A report on the global AIDS epidemic published ... pandemic, which has left 12 million children orphaned in Sub-Saharan ...
(Date:4/14/2014)... marvels of the 20th century, is currently losing a ... But scientists at the University of South Carolina have ... effectiveness, even against so-called "superbugs." , Bacteria have been ... of drugs since their first wide-scale use as antibiotics ...
(Date:4/14/2014)... ,, West Orange, NJ. April 10, 2014. John DeLuca, ... grant from Biogen Idec to study how persons with ... entitled "The Use of Actual Reality to Measure Everyday ... to conduct this research. Dr. DeLuca is senior VP ...
(Date:4/14/2014)... that the molecule, called microRNA 135b, is a vital ... the growth of bowel cancers. , Drugs targeted at ... cancer-causing mutations at once, while tests for it could ... believe. , The research was carried out by an ...
(Date:4/14/2014)... -- with symptoms increasing dramatically during some of the most ... study has found. , Depressive symptoms increased on average by ... these young men, who were around 25 years old when ... as their children. The results of the study were published ...
Breaking Medicine News(10 mins):Health News:Researchers identify children with emotional behavior difficulties 2Health News:Researchers identify children with emotional behavior difficulties 3Health News:Penicillin redux: Rearming proven warriors for the 21st century 2Health News:Penicillin redux: Rearming proven warriors for the 21st century 3Health News:'MicroRNA' could be key target for bowel cancer treatment 2Health News:Young dads at high risk of depression, too 2
... with network providers, WOODLAND HILLS, Calif., April ... had the highest workplace,absenteeism at 2,761,000 lost work ... to cost employers $522 million annually. Anthem Blue ... to help identify and resolve issues that they ...
... from Innovative Program, SEATTLE, April 16 ... partnering with Technogym USA to bring the finest,fitness ... Technogym,The Wellness Company is the official fitness equipment ... of retirement living,communities are comparable to five-star hotels. ...
... should lead to more effective vaccines, researchers say , , WEDNESDAY, ... virus that produce seasonal flu epidemics start in East Asia ... world, researchers report. , And by focusing on new flu ... their forecast of seasonal flu strains and develop better vaccines, ...
... to extend the reach of their High ... Dropout Prevention ,Boost, Campaign, NEW YORK, April 16 The ... Call program as part of their "Boost",national public service advertising campaign ... of Amare Stoudemire, NBA,All-Star and Captain of the Phoenix Suns, the ...
... Hit Especially Hard, According to New NCPA,Study, DALLAS, ... the greatest penalties on low-income workers when they work,extra ... today by the,National Center for Policy Analysis., "The ... said NCPA Senior Fellow Laurence Kotlikoff, Boston University,professor and ...
... - Higher blood levels of an immune system protein ... disease, researchers at The University of Texas M. D. ... of the American Association for Cancer Research. , Their ... marker of poor prognosis also points to a molecular ...
Cached Medicine News:Health News:Anthem Blue Cross Employee Assistance Program to Help Reduce Employee Absenteeism 2Health News:AegisLiving Partners With Technogym USA to Enhance Wellness Throughout Its' Communities 2Health News:AegisLiving Partners With Technogym USA to Enhance Wellness Throughout Its' Communities 3Health News:Seasonal Flu Outbreaks Start in Asia: Study 2Health News:Seasonal Flu Outbreaks Start in Asia: Study 3Health News:Video: Phoenix Suns' Amare Stoudemire Kicks Off Program to Encourage Teens to 'Wake Up' and Go to School 2Health News:Video: Phoenix Suns' Amare Stoudemire Kicks Off Program to Encourage Teens to 'Wake Up' and Go to School 3Health News:Video: Phoenix Suns' Amare Stoudemire Kicks Off Program to Encourage Teens to 'Wake Up' and Go to School 4Health News:Video: Phoenix Suns' Amare Stoudemire Kicks Off Program to Encourage Teens to 'Wake Up' and Go to School 5Health News:Tax Rates Mean Extra Work Doesn't Pay 2Health News:Interleukin-12 indicates survival prospects for melanoma patients 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: